Search

Your search keyword '"Marsillach J"' showing total 124 results

Search Constraints

Start Over You searched for: Author "Marsillach J" Remove constraint Author: "Marsillach J"
124 results on '"Marsillach J"'

Search Results

1. Paraoxonase 1 and Postprandial Lipemia

7. Paraoxonase-1 Deficiency Is Associated with Severe Liver Steatosis in Mice Fed a High-fat High-cholesterol Diet: A Metabolomic Approach

8. Altered paraoxonase expression in patients with genetic haemochromatosis

9. Paraoxonase 1 and Postprandial Lipemia

17. Paraoxonase-1 in Chronic Liver Diseases, Neurological Diseases and HIV Infection.

18. Paraoxonase 1 and Postprandial Lipemia.

19. Is there a relationship between cystatin C and inflammatory status, oxidative stress and other cardiovascular risk factors in non-diabetic patients with chronic kidney disease?

20. Decreased paraoxonase-1 activity is associated with alterations of high-density lipoprotein particles in chronic liver impairment

21. Methodological constraints in interpreting serum paraoxonase-1 activity measurements: an example from a study in HIV-infected patients

22. Paraoxonase-1 is related to inflammation, fibrosis and PPAR delta in experimental liver disease

23. PON1 Status in Relation to Gulf War Illness: Evidence of Gene-Exposure Interactions from a Multisite Case-Control Study of 1990-1991 Gulf War Veterans.

24. Inhibition with simultaneous spontaneous reactivation and aging of acetylcholinesterase by organophosphorus compounds: Demeton-S-methyl as a model.

25. Reduction of Paraoxonase Expression Followed by Inactivation across Independent Semiaquatic Mammals Suggests Stepwise Path to Pseudogenization.

26. Lipoprotein-Associated Phospholipase A2 Activity as Potential Biomarker of Vascular Dementia.

27. Examining the role of paraoxonase 2 in the dopaminergic system of the mouse brain.

28. Paraoxonase-1 (PON-1) Arylesterase Activity Levels in Patients with Coronary Artery Disease: A Meta-Analysis.

29. Paraoxonase 2 deficiency in mice alters motor behavior and causes region-specific transcript changes in the brain.

30. Evaluating Gait and Locomotion in Rodents with the CatWalk.

31. Interdisciplinary data science to advance environmental health research and improve birth outcomes.

33. Paraoxonase-1 and -3 Protein Expression in the Brain of the Tg2576 Mouse Model of Alzheimer's Disease.

34. Connection between the Altered HDL Antioxidant and Anti-Inflammatory Properties and the Risk to Develop Alzheimer's Disease: A Narrative Review.

35. Paraoxonase-1 (PON1) Status Analysis Using Non-Organophosphate Substrates.

36. HDL Proteome and Alzheimer's Disease: Evidence of a Link.

37. Evaluating the link between Paraoxonase-1 levels and Alzheimer's disease development.

38. Ancient convergent losses of Paraoxonase 1 yield potential risks for modern marine mammals.

39. Metals and Paraoxonases.

40. Developmental expression of paraoxonase 2.

41. Paraoxonases-1, -2 and -3: What are their functions?

42. Paraoxonase-1 and Early-Life Environmental Exposures.

43. Paraoxonase-3 is depleted from the high-density lipoproteins of autoimmune disease patients with subclinical atherosclerosis.

44. Announcing our finalists.

45. Human valacyclovir hydrolase/biphenyl hydrolase-like protein is a highly efficient homocysteine thiolactonase.

46. Rare coding variation in paraoxonase-1 is associated with ischemic stroke in the NHLBI Exome Sequencing Project.

47. Impaired paraoxonase-1 status in obese children. Relationships with insulin resistance and metabolic syndrome.

48. Pharmacogenetics of paraoxonase activity: elucidating the role of high-density lipoprotein in disease.

49. Paraoxonase-1 is associated with corneal endothelial cell alterations in patients with chronic obstructive pulmonary disease.

50. Paraoxonase 1 (PON1) as a genetic determinant of susceptibility to organophosphate toxicity.

Catalog

Books, media, physical & digital resources